Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Early-onset patients have greater 11C-PBR28 binding than late-onset patients
While no prediction is a guarantee of success, this information can help in the choice of which drugs to test first in patients, as well as which are the least likely to succeed
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
[9] In summary, while NAD+ Injection is a broadly applicable metabolic therapy, it should not be used by anyone allergic to it, and it is generally avoided in pregnant women, cancer patients, or those with serious chronic diseases, absent compelling medical rationale
Important note: This is educational, not medical advice
Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining , 785794 (San Francisco California USA: ACM)
US$ 22.51
US$ 29.69
US$ 22.96
US$ 26.71
US$ 29.37
US$ 25.82
US$ 21.29